Needle-free Covid vaccines could be the key to beating the virus Mucosal vaccines are delivered in your nose or throat, as sniffable or inhalable formulation Wales Online · Nov 8, 2022
Pill to prevent pre-eclampsia gets UK fast track for development Exclusive: MHRA grants innovation passport to drug that could prevent women from developing condition The Guardian - UK · Nov 8, 2022
‘Exciting’ new drug found to reduce blood pressure in patients resistant to treatment Trial finds drug Baxdrostat to be successful in bringing down blood pressure Evening Standard · Nov 7, 2022
‘Exciting’ development in tackling untreatable high blood pressure Those who took a new drug during a clinical trial were found to have significantly lower blood pressure after other traditional medicines had failed. The Independent UK · Nov 7, 2022
New drug could help tackle 'untreatable' high blood pressure Researchers said those given it during a clinical trial were found to have significantly lower blood pressure Wales Online · Nov 7, 2022
Study shows ‘significant drop’ in confidence in vaccines since start of Covid Scientists warn Covid jab met with ‘particular hostility’ despite evidence of safety Evening Standard · Nov 7, 2022
BioNTech earnings drop but forecast for vaccine income grows BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported that third-quarter earnings are close to half what they were a year earlier The Independent UK · Nov 7, 2022
1 Stock to Buy This Week Following Its Recent Earnings Beat Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think… StockNews.com · Nov 7, 2022
Uganda still struggling to tackle Ebola as the death toll passes 50 Health authorities in Uganda are struggling to contain the Ebola virus after reporting 51 deaths, including healthcare workers and 132 cases across seven districts in the country. While some government-instituted lockdowns have been put in place, the International Rescue Committee is calling for more funding to curb the spread of… Radio France Internationale · Nov 7, 2022
3 Biotech Stocks to Accumulate During the Bear Market 2022 has been a challenging year for investors due to the combination of inflation and a slowing economy. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals. Amgen (AMGN), Corcept Therapeutics (CORT), and Regneron (REGN) are 3 to consider. StockNews.com · Nov 7, 2022
Ebola spreads despite lockdown as death toll of killer virus passes 50 Covid-style lockdowns have been extended in Uganda with more than 50 deaths reported since the start of the outbreak. Daily Mirror · Nov 7, 2022
How long can you test positive for Covid and when are you infectious? A surge in cases is indicating a new wave has started in the UK The Independent UK · Nov 7, 2022
Nine Covid symptoms affecting the fully vaccinated — and signs you may have it Fainting and fatigue may signal onset of variant, experts say The Independent UK · Nov 7, 2022
Confidence in vaccines plummets since start of Covid-19 pandemic The fall is across the board and comes regardless of age, gender, religious belief, education or ethnicity Wales Online · Nov 7, 2022
Daily Mirror · Nov 7, 2022 Long Covid sufferers still battling with virus three years on from getting infected More than two million people in the UK are believed to have Long Covid, with the longest sufferers said to have fallen ill with the virus before the pandemic began
Tribune News Service · Nov 7, 2022 Pfizer’s Paxlovid antiviral drug lowered risk of long COVID symptoms in study Pfizer Inc.’s blockbuster Paxlovid antiviral that lowers rates of illness and death in people infected with the coronavirus also cuts the risk of some symptoms of disabling long COVID, a study found.
360info · Nov 7, 2022 A united front in fight against the 'silent pandemic' Antimicrobial resistance is one of the biggest public health challenges of our time and we’re at a crossroads on how to combat it.
Reuters · Nov 6, 2022 Former Petrobras executive asks Brazil court to block dividend payment Guilherme Estrella, former director of Brazil's state-controlled oil giant Petrobras, filed a lawsuit in court to block the payment of dividends by the company. In a late Friday filing, Petrobras reported that Estrella, a former director of exploration and production, requested the blocking of 32.1 billion reais ($6.6 billion) in…
The Independent UK · Nov 6, 2022 Nine Covid symptoms affecting the fully vaccinated — and signs you may have it Fainting and fatigue may signal onset of variant, experts say
Irish Mirror · Nov 6, 2022 Irish pharmacies running low on vital diabetes drug after viral TikTok video reveals weight loss benefits Hundreds of videos followed with people explaining how the injectables can be used for effective weight loss when prescribed by a GP
The Guardian - US · Nov 6, 2022 These companies claim to support abortion rights. They are backing anti-abortion Republicans An analysis of major companies’ donations, including Meta and Amazon, reveals donations to candidates calling for banning the procedure
Reuters · Nov 6, 2022 China posts 6-month high COVID count as it sticks with strategy China on Sunday reported its highest number of new COVID-19 infections in six months, a day after health officials said they were sticking with strict coronavirus curbs, likely disappointing recent investor hopes for an easing.
Newcastle Herald · Nov 6, 2022 The COVID drug under a cloud that made billions 'It's a big deal because the Australian government purchased a huge amount of that drug.'
Tribune News Service · Nov 6, 2022 Regeneron, Bayer offer more promising data for aging eye drug Bayer AG and Regeneron Pharmaceuticals Inc.’s blockbuster eye drug reached another clinical milestone by showing sustained efficacy in trials that could help the companies push back against a competing product from Roche Holding AG.
Daily Mirror · Nov 5, 2022 NHS could pay higher drug prices if Brexit trade deal with India goes ahead India supplies the NHS with a quarter of its medicines and changes to pharma monopoly rights and patent laws under leaked plans could see costs spiral